Estrogens and Progestins (Exam 1) Flashcards
Three pharmacotheraputic applications of hormones
Hypofunction: menopausal hormone therapy
Hyperfunction: suppression of production, cancer
Alteration of normal endocrine states: combined oral contraceptives
Women who take combination oral contraceptives:
A. Have a higher risk of ovarian cancer
B. Have a higher risk of endometrial cancer
C. Have a reduced risk of both ovarian and endometrial cancer
D. Have a higher incidence of benign breast disease
C
SERMs (tamoxifen and Raloxifene) have anatagonistic actions of what functions/ tissues?
Breast
Vasomotor
Endometrium - raloxifene only
- A 70-year-old woman is being treated with raloxifene for
osteoporosis. Which of the following is a concern with this
therapy?
A. Breast cancer
B. Endometrial cancer
C. Hot flashes
D. Hypercholesterolemia
C
SERMs and Estrogen have a adverse effect of ________ because of increasing clotting factors
VTE
Estrgoen _______ LDL and _______ HDL
decreases, increases
SERMs have an adverse effect of _______ because of the antagonistic effect of vasomotor function
hot flashes
Medications used for MHT:
Ethinyl estradiol (conjugated estrogens), estradiol (topical), progesterone- medroxyprogesterone (for pts with intact uterus)
. A thin, dry vaginal lining and thin urethral mucosa can
cause:
A. Vaginal and vulvar burning and irritation
B. Pain during intercourse
C. An increased risk of urinary tract infections
D. All of the above
D
An oral alternative to vaginal estradiol for vaginal symtptoms of menopause
Ospemifene - SERM
Adverse rxns of ospemifene
endometrial hyperplasia, VTE risk, hot flashes
non hormonal drug that is FDA approved for hot flashes
paroxetine
. The most effective treatment for vasomotor symptoms of menopause is: A. Systemic estrogen B. A low-dose vaginal estrogen C. Ospemifene D. Paroxetine
A
Which of the following is recommended for women
with genitourinary syndrome of menopause without
vasomotor symptoms?
A. An oral estrogen
B. A low-dose vaginal estrogen
C. An oral progestogen
D. Low-dose paroxetine
B
Which of the following would be appropriate for
treatment of a 52-year-old menopausal woman with an
intact uterus and a history of venous thromboembolism
who is complaining of severe hot flashes that are
keeping her awake at night?
A. A transdermal estrogen/progestin
B. Ospemifene (a SERM)
C. Conjugated estrogens/bazedoxifene (a SERM)
D. Low-dose paroxetine
A